Target intelligence / Profile preview

5-iodo-4-hydroxy-3-nitrophenylacetyl (NIP)

Target
NIP
Molecular classification
Hapten, Chemical tool, Small molecule
01

Overview

5-iodo-4-hydroxy-3-nitrophenylacetyl (NIP) is a synthetic hapten widely utilized in immunological research as a model antigen (PubChem CID: 12313450). As a hapten, it is a small molecule that is not immunogenic by itself but can elicit a robust immune response when conjugated to a larger carrier protein like bovine serum albumin (BSA) or chicken gamma globulin (CGG) (PubMed: 701734). It is frequently employed in studies of B-cell activation, antibody affinity maturation, and the structural basis of antigen-antibody interactions (PubMed: 6159784). Researchers often use NIP alongside its analog, 4-hydroxy-3-nitrophenylacetyl (NP), to measure changes in antibody affinity, as specific mutations in immunoglobulin genes can shift preference between these two related structures (PubMed: 3917421). While it is a critical tool for understanding the immune system, it is not a therapeutic target or a biological receptor found naturally in the human body.

Other names
NIP4-hydroxy-3-iodo-5-nitrophenylacetylNIP-hapten3-iodo-4-hydroxy-5-nitrophenylacetyl
02

Mechanism of action

Not applicable; NIP is a synthetic hapten used in research to study antibody production and affinity maturation rather than a therapeutic target.

03

Biological functions

Antigenic determinantImmune response induction
04

Safety considerations

Immunogenicity (intended for research purposes)

Beyond the preview

Go deeper on 5-iodo-4-hydroxy-3-nitrophenylacetyl (NIP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-iodo-4-hydroxy-3-nitrophenylacetyl (NIP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call